XML 58 R46.htm IDEA: XBRL DOCUMENT v3.21.1
Intangible Asset - Nucynta Commercialization Agreement - Table (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 11 Months Ended
Feb. 05, 2020
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Feb. 29, 2020
Dec. 31, 2019
Gross carrying amount   $ 521,170   $ 521,170    
Amortization expense   (16,795) $ (10,295)      
Accumulated amortization   (202,061)   (185,266)    
Intangible assets, net   319,109   335,904    
Nucynta Products            
Gross carrying amount   521,170   521,170   $ 154,089
Amortization expense $ (1,754) (16,795)   (58,926)    
Accumulated amortization   (202,061)   (185,266)   (124,586)
Additional costs incurred         $ 367,081  
Intangible assets, net   $ 319,109   $ 335,904   $ 29,503